Global In Vitro Screening Market Growth (Status and Outlook) 2023-2029
LPI (LP Information)' newest research report, the “In Vitro Screening Industry Forecast” looks at past sales and reviews total world In Vitro Screening sales in 2022, providing a comprehensive analysis by region and market sector of projected In Vitro Screening sales for 2023 through 2029. With In Vitro Screening sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world In Vitro Screening industry.
This Insight Report provides a comprehensive analysis of the global In Vitro Screening landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on In Vitro Screening portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global In Vitro Screening market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for In Vitro Screening and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global In Vitro Screening.
The global In Vitro Screening market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for In Vitro Screening is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for In Vitro Screening is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for In Vitro Screening is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key In Vitro Screening players cover Thermo Fisher Scientific, PerkinElmer, Merck, Charles River, Pharmaron, Reaction Biology, Eurofins Discovery, Frontage Laboratories and Atlantic Bone Screen, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of In Vitro Screening market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Enzymes
Ion Channels
GPCRs
Nuclear Receptors
Protein-protein Interactions
Segmentation by application
Oncology
Immunology
Metabolic Diseases
CNS
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Thermo Fisher Scientific
PerkinElmer
Merck
Charles River
Pharmaron
Reaction Biology
Eurofins Discovery
Frontage Laboratories
Atlantic Bone Screen
Intertek
Visikol
Evotec
Tergus Pharma
QIMA Life Sciences
Wuxi Biortus Biosciences
ICE Bioscience
Viva Biotech
Topscience
Please note: The report will take approximately 2 business days to prepare and deliver.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook